Updated: Nov 12, 2009
Vesicoureteral reflux (VUR) is the abnormal flow of urine from the bladder into the upper urinary tract and the most common urologic disease in childhood. Its presence is pathologic, and it represents the most significant risk factor for childhood renal scarring and its sequelae.1,2,3,4,5,6,7,8,9,10
The majority of cases (90%) in children represent a primary congenital failure of the natural passive 1-way mechanism of the ureterovesical junction (UVJ) to maintain unidirectional urine flow. A minority of VUR cases (10%) occur secondary to abnormalities of the ureteral insertion in association with renal transplantation, ureterocele (see Images 2-5), ureteral duplication anomalies (see Image 1), obstruction of the bladder outlet (posterior urethral valves in boys, see Image 6), dysfunctional voiding, or constipation.
Leonardo da Vinci was the first to describe and depict the UVJ. VUR was demonstrated experimentally in 1883, and the initial observation of VUR in humans was recorded in 1893. Reflux occurs naturally in some other species, including dogs, cats, and rabbits.
There is a documented association of VUR with congenital upper urinary tract abnormalities such as renal agenesis, multicystic dysplastic kidney, and obstruction of the ureteropelvic junction (UPJ).
Recent studies
According to Fefferman et al, fluoroscopically captured images are adequate in documenting the absence of vesicoureteral reflux (VUR) on VCUG examinations, making radiographic spot images unnecessary and thereby reducing patient exposure to radiation. The authors retrospectively reviewed 65 VCUG exams, each consisting of fluoroscopically captured spot (FCS) images and corresponding digital radiographic spot (DRS) images. The diagnostic accuracy of the FCS images regarding binary characterization of reflux as negative or positive was 97.2%; the sensitivity of the FCS images was 92.6%; and the specificity of the FCS images was 98.6%.1
In a retrospective cohort study by Novak et al using data from the North American Pediatric Renal Trials and Collaborative Studies Registry, children with VUR were found to have a slower rate of progression to end-stage renal disease than children with renal aplasia, hypoplasia or dysplasia, and other causes of chronic kidney disease. In children with VUR as the cause of chronic kidney disease, the factors of older age, higher stage of chronic kidney disease, and history of urinary tract infection were significantly associated with the risk of progression to end-stage renal disease.2
Menezes and Puri, in a study of 251 siblings of 215 index patients with grade III to 5 VUR, noted that the familial nature of VUR is well recognized but that the screening of siblings for VUR remains controversial. In their study, the authors found that the incidence of sibling VUR is maximal in patients younger than 3 years and that reflux in these patients is usually high grade and associated with a higher incidence of renal scarring. Of the 251 siblings with reflux, 105 were diagnosed after a urinary tract infection and 146 after screening. A total of 207 siblings were younger than 3 years, and 44 were 3-6 years of age. Renal scarring was present in 35.5% of symptomatic siblings and in 15% of screened siblings. The authors recommended that screening be performed on all siblings who are younger than 3 years of index patients with grades III to V VUR.3
Renal scarring
Incomplete bladder emptying is a contributory factor, and post-voiding residual urine acts as a fertile incubation medium for urinary pathogens, predisposing children with vesicoureteral reflux (VUR) to pyelonephritis and resultant renal scarring.4 Radiologic evidence of renal scarring is present in 30-60% of children with VUR, and VUR is present in almost all children (97%) with severe renal scarring. However, most kidneys (60%) with acute cortical defects do not demonstrate reflux, which highlights that ascending urinary tract infection (UTI) is quite common despite the absence of demonstrated VUR.
The kidney is most susceptible to scarring from intrarenal reflux in the first year of life and probably at the time of first upper tract infection.5 Renal scars less frequently develop after age 5 years. New renal scars develop almost exclusively in the presence of UTI and intrarenal reflux, but the presence of intrarenal reflux alone does not equate with renal scarring. Infected urine is believed to cause an exudative reaction that leads to fibrosis and scarring of papillae. Intrarenal reflux is a phenomenon that is likely underreported due to its fleeting nature and occurrence at peak reflux.
Lower grades of reflux without bacteriuria probably cause no significant renal damage, although the subject has been debated.
Severity of reflux
The severity of VUR is directly related to the risk of pyelonephritis and subsequent renal scarring. VUR and renal scarring may lead to severe hypertension (in 10-20% of cases, mostly female), progressive renal insufficiency, and renal failure.
VUR is or has been present in 30-49% of children who have renal failure before age 16 years and in 20% of adults who have renal failure before age 50 years.
Reflux nephropathy is thought to be responsible for 10-30% of all cases of end-stage renal disease. Renal growth is impaired in patients with ongoing reflux and UTI. Spontaneous resolution of reflux or resolution after therapy allows for resumption of renal growth, but the affected kidney never catches up.
Vesicoureteral reflux (VUR) occurs more commonly in children who have had urinary tract infection (UTI) than in those with sterile urine, affecting about 0.4-1.8% of children without UTI, 14-35% of children with asymptomatic UTI, and 25-50% of children with symptomatic UTI undergoing voiding cystourethrography (VCUG).
In pediatric patients with UTI, an average of 35% (18-50%) are diagnosed with reflux. Some researchers hold that the prevalence of this condition in randomly selected children may be as high as 17%.
VUR is inherited in an autosomal dominant pattern with variable expression. The child of a parent with VUR has a 66% likelihood of having reflux and the sibling of a child with reflux has a 25-50% likelihood of being similarly afflicted. The risk of sibling reflux increases even further when evidence of renal damage is present in the index case.
About 75% of the siblings of patients are asymptomatic, and 20% of siblings of patients with dysfunctional voiding have reflux.
The natural history of vesicoureteral reflux (VUR) is that it resolves spontaneously in childhood at a rate of about 10-15% per year.
Reflux is 10-20 times less frequent in black girls than in other girls.
Overall, about 75% of patients with vesicoureteral reflux (VUR) are girls.
The average patient age at diagnosis is 2-3 years.
The pressure of bladder urine against the intravesical submucosal tunnel of the distal ureter effectively keeps it closed, except when ureteral peristalsis actively propels urine through it. The tunneled segment acts as a mainly passive 1-way valve. (There is a small contribution from the ureterotrigonal longitudinal muscles and ureteral peristalsis.)6
In primary vesicoureteral reflux (VUR), abnormal anatomic features are present: laterality of position, superior ectopia of a patulous ureteral orifice, a perpendicular (rather than oblique) course of the ureter through the bladder wall and a shortened intramural segment of ureter. The ratio of the submucosal tunnel length to the ureteral diameter is the primary factor determining the effectiveness of the normal valve mechanism. In healthy individuals, the ratio is typically 5:1, whereas it is about 1.4:1 in those with VUR. The intramural ureter increases in length from 0.5 cm at birth to 1.3 cm (adult length) by about age 12 years. The severity of reflux is proportional to the degree of anatomic abnormality.
Reflux is usually greatest and may be demonstrated only during the initiation or cessation of voiding, corresponding to the elevation in bladder pressure.
Intrarenal reflux favors the polar regions of the kidneys where there is a relative abundance of compound papillae that have larger, more perpendicularly oriented and concave duct orifices opening to the calyces. The obliquely oriented, slitlike convex duct orifices of the simple papillae found mostly in the mid kidney close readily with increased intrapelvic pressure, thereby preventing intrarenal reflux. Overall, at least two thirds of papillae in human kidneys are concave and have the potential to permit intrarenal reflux of urine.
The relationship between vesicoureteral reflux (VUR) and infection is close and complicated. Despite a few lingering disagreements, it is now commonly agreed that VUR of infected urine is the major cause of pyelonephritis in children. A child with reflux is more likely to have pyelonephritis than a child without reflux, yet there is no significant difference in the incidence of sterile (88-90%) and infected (10-12%) urine in children who do not have reflux compared with those who do. The issue of whether infection can produce significant VUR without some underlying abnormality has been a point of contention. Some reflux may occur secondary to urinary tract infection (UTI), but this generally resolves spontaneously with treatment of the infection and disappearance of the inflammatory changes at the UVJ.
The symptomatic presentation of VUR is almost always in conjunction with an associated UTI. Fever is considered the most important symptom in differentiating upper tract infection (pyelonephritis) from lower tract infection (cystitis). Distinguishing between the two on clinical grounds is difficult in young children.
An important risk factor for recurrent UTI and VUR is voiding and elimination dysfunction. This may be due to a small bladder volume, uninhibited bladder contractions, or bladder overdistention from willful infrequent voiding. Primary VUR takes 1.5 years longer to resolve in children with dysfunctional urinary and fecal elimination, and there are more breakthrough infections and reimplantation surgeries than in those without this condition. The diagnosis of dysfunctional elimination in patients with VUR is important because effective nonoperative treatments exist that have been shown to reduce the number of UTIs and promote the resolution of VUR. Some contrary data has recently been published where no association between the diagnosis of UTI or VUR and dysfunctional elimination in school-aged children of the general pediatric population.
VUR is the most common abnormality associated with complete ureteral duplication. Approximately 10% of children undergoing antireflux surgery have complete or incomplete duplication of the collecting system. In only 22% of patients with renal duplication does VUR spontaneously resolve. Imaging of completely duplicated ureters in patients with VUR most often follows the Weigert-Meyer rule: The upper pole, often obstructed, ectopic ureteral orifice inserts medial and caudal to the often refluxing lower pole ureteral orifice. Reflux occurs 3 times more often into the lower pole ureter.
VUR is associated with UPJ obstruction. The incidence of reflux in patients with UPJ obstruction has been reported as 5-24%. Deciding which of the two is the more significant lesion is sometimes a challenge in uroradiology.
Voiding cystourethrography (VCUG) is the screening urologic imaging study of choice. American urologists, pediatricians, and radiologists recommend this study to detect vesicoureteral reflux (VUR), ureterocele (see Image 4), posterior urethral valves in boys (see Image 6), or bladder wall thickening (see Image 29).
Up to 50% of children with proven urinary tract infection (UTI) undergoing VCUG have some degree of reflux. Sonography of the kidneys should be performed in conjunction with VCUG to document the size of the kidneys and to look for obstruction, hydronephrosis, or other congenital malformations.7
When VUR is found to distend the upper tract, postvoiding decompression at the upper tracts should be observed.
Reflux is generally intermittent and may escape detection on voiding cystourethrogram (VCUG). This difficulty may be compounded by the desire to limit the child's exposure to ionizing radiation as much as possible. The influence of body position on the occurrence and detection of reflux has not been well studied in children. Incomplete bladder filling decreases the sensitivity of the study.
Bladder, Cystitis
Multicystic Dysplastic Kidney
Posterior Urethral Valve
Reflux Nephropathy
Ureterocele
Megaureter
Neurogenic bladder
Bladder neck obstruction
Posterior urethral valve
Dysfunctional voiding
The diagnosis of vesicoureteral reflux (VUR) is accurately established with fluoroscopic voiding cystourethrography (VCUG). This study permits assessment for the presence and extent of reflux, and it clearly delineates the bladder outline, bladder neck, and ureteral and urethral anatomy. Fluoroscopic VCUG also gives an accurate estimation of bladder capacity.
The retention of contrast material within the upper tracts after voiding without decompression suggests UPJ or ureterovesical junction (UVJ) obstruction. VUR may occur with bladder filling, during voiding, or both. Cyclical VCUG, repeated bladder filling and fluoroscopic examination, which is primarily performed in patients younger than 1 year, depicts reflux an additional 10% of the time.
In children older than 3-4 years who have signs only of lower UTI, VCUG is not recommended if renal sonograms are normal. Whether VCUG is done while the initial UTI is being treated or several weeks afterward is not important, so long as the child is responding appropriately to treatment and has normal bladder function. VCUG may be performed as soon as the urine is sterile and bladder irritability has disappeared.
VUR is graded according to the International Reflux Classification outlined by the International Reflux Study Group in 1985. This classification scheme is widely accepted and no new schemes have been introduced.
Intrarenal reflux appears as contrast medium extending from the calyces into the polar renal collecting tubules in the form of striations. This can be identified most often in neonates and infants with moderate or severe reflux (5-15%). The presence of intrarenal reflux does not change the grade or treatment of VUR.
Nuclear imaging and sonography have replaced excretory urography (EU) as the preferred radiologic examination of the upper urinary tract. On excretory urograms, the scars of reflux nephropathy are typically detected about 2 years after infection. When uncomplicated, they have characteristic imaging features that include a deformed (clubbed) calyx and thinning of the overlying renal parenchyma, often with a notch in the surface of the kidney immediately opposite the affected calyx. Ureteral dilatation suggesting VUR may also be seen.
EU is a modality rarely used in the modern assessment of VUR. It can demonstrate renal scarring but is less sensitive than DMSA or GH scintigraphy. The use of EU is exceptional and indicated only in those cases presenting with confusing collecting system anatomy or where demonstration of the calyces is important.
Although CT can provide excellent anatomic and functional information in children with reflux nephropathy, it does not currently have a primary role in the usual diagnostic algorithm or follow-up of such children. Still, hydronephrosis and ureteral dilatation are easily seen in patients with vesicoureteral reflux (VUR) who happen to undergo CT examination (see Images 21-22).
Although MRI can provide excellent anatomic and functional information in children with reflux nephropathy, it does not currently have a role in the usual diagnostic algorithm or follow-up of such children.
The widespread use of prenatal sonography has produced a marked increase in the early detection of urinary-tract pathology in infants. The most common conditions identified are hydronephrosis and hydroureteronephrosis. Hydronephrosis is most often transient, but primary VUR is found in 10-40% of prenatally detected cases of hydronephrosis.
Prenatally detected primary vesicoureteral reflux (VUR) is found in males (male-to-female ratio, 5:1) most of whom have bilateral high-grade reflux.8 Low-grade reflux is often associated with other prenatal urologic abnormalities. Mild pelviectasis is seen in 0.5-1% of all pregnancies. The significance of mild pelvic and/or pelvicaliceal dilatation as a marker of VUR is poorly validated but dilatation beyond 15 mm has proven significant and should prompt a thorough search for other urologic abnormalities.
The neonate with sonographic signs of renal pathology and possible reflux should be given prophylactic antibiotics and examined with voiding cystourethrography (VCUG). The risk of renal scarring from neonatal and infant pyelonephritis is too great to ignore.
Generally speaking, ultrasonography is an unreliable modality for the detection of VUR. It cannot be used as the sole means to exclude clinically significant VUR, even when the results are normal. Nevertheless, clues to the presence of VUR can be inferred from certain sonographic findings, namely complete duplication, peristaltic ureteral dilatation and calyceal dilatation. Sonographic measurement of kidney size is an important aspect of the screening examination. An abnormally small kidney in the child suggests parenchymal thinning, even in the absence of visible scar.
Ultrasonography is best used in conjunction with screening VCUG to assess for renal size; upper tract abnormalities, such as hydronephrosis and ureteral dilatation (see Images 13, 25-28); obvious scarring; ureteral ectopia or bladder abnormalities, such as ureterocele (see Images 2-3); and bladder wall thickening (see Images 23-24).
Obtaining reproducible sonograms is highly operator dependent. Full assessment of the bladder and urethra can sometimes be difficult. Smaller scars are less well visualized with sonography than with technetium-99m dimercaptosuccinic acid (DMSA) or glucoheptonate (GH) cortical scanning.
Sonography has been proposed for following up of patients with reflux or for detecting reflux in siblings. New techniques involve instilling carbonated solutions or sonicated albumin into the bladder. Presently, the false-negative rate associated with this procedure is high, and it is not recommended as a routine test for VUR.
Approximately 74% of kidneys with reflux at VCUG were normal on sonograms obtained on the same day, and approximately 25% of the refluxing kidneys that are missed have reflux of grade III or worse.
The results of sonographic evaluation for hydronephrosis or pelvicaliceal dilatation may vary greatly between the second and third trimesters. Abnormalities may not be detectable until the third trimester, later than the common second trimester screening examination.
Direct radionuclide cystography with a99m Tc-labeled agent (sulfur colloid, diethylenetriamine penta-acetate [DTPA], or pertechnetate) is a well-accepted alternative to fluoroscopic VCUG for screening asymptomatic siblings or offspring, for follow-up examination of children with vesicoureteral reflux (VUR), for postoperative evaluation after ureteral reimplantation, and for excluding VUR when it is not seriously considered (especially in girls).
The advantages of this study include continuous monitoring and imaging, high sensitivity, and a decreased radiation dose for a voiding imaging study. The dose to the pelvic organs was much more significantly lower when the study was popularized in the screen film cassette spot film era of former fluoroscopic equipment. With modern digital fluoroscopy units that reduce dose by pulsed fluoroscopy or other dose reduction strategy combined with video frame grabbing spot images, the dose reduction advantage of the isotope cystogram is only marginal.
Patients with VUR are typically followed up with serial radionuclide cystography every 12-24 months. The International Classification of Reflux is not commonly applied to radionuclide studies, but the amount of activity that appears in the upper urinary tracts can be quantified into 1 of 3 levels of severity and used as a basis of comparison in serial follow-up examinations (see Image 19).
The indirect radionuclide cystogram (no catheterization) using99m Tc mercaptoacetyltriglycine (MAG3) can be performed in the toilet-trained child, but its specificity is decreased. It is not recommended as a routine screening procedure for evaluating VUR.
The most accurate evaluation of renal scarring and renal function is performed with intravenously injected99m Tc DMSA or GH. DMSA accumulates in the distal tubular cells and provides excellent visualization of the renal cortex, correlating with histopathologic findings in 95% of experimental animals.
Single photon emission computed tomography (SPECT) is superior to planar imaging techniques, especially in children younger than 3 years. Renal scars detected with DMSA scintigraphy appear as focal or generalized areas of diminished radioisotope uptake associated with loss or contraction of functioning renal cortex. This may appear as thinning or flattening of the cortex in some kidneys, while in others renal scars appear as classic discrete wedge-shaped parenchymal defects (see Image 20).
About 63-75% of patients with acute inflammatory changes on the initial DMSA renal scans do not have VUR, and reflux is present in only 25-50% of kidneys that develop new renal scarring. Although not a prerequisite for acquired renal scarring, VUR is still a risk factor that cannot be discounted and should be evaluated.
Direct radionuclide cystography (continuous monitoring) is more sensitive than VCUG. It can depict as little as 1 mL of refluxed urine and exposes the patient to less radiation.
Grade I reflux affects the ureter only, grade II reflux involves the kidney with no pelvic dilatation, and grade III reflux is reflux with pelvic dilatation (see Image 19).
Renal cortical scintigraphy demonstrates twice as many scars as sonography and 4 times as many scars as EU.
Any reflux is abnormal.
99m Tc pertechnetate may be systemically absorbed through an inflamed bladder wall.
If a DMSA or GH study is being performed to detect reflux nephropathy with scar formation, it should be undertaken at least 6 months after a documented UTI because an upper-tract infection causes an abnormal appearance on DMSA or GH scans. Abnormalities resulting from infection are transient, whereas scars result in a permanent abnormality.
In the setting of acute infection, granulocyte aggregation, complement activation, and compression of the renal microcirculation from interstitial edema cause ischemia. Overall, the effect is of reduced regional blood flow and radiotracer uptake. Although this may be a transient phenomenon, it cannot be distinguished from scarring in the acute setting.
Intervention for VUR remains a controversial topic. Guidelines for medical and surgical management are constantly being reassessed. For many years, the emphasis on the investigation of the child with UTI has centered on diagnosis of VUR. More recently, some authors have suggested that the focus should be whether the child has renal scarring or is at risk for renal scarring. The natural tendency for VUR to resolve spontaneously during childhood warrants initial medical management of most patients with low-grade reflux. Image 31 shows the usual treatment algorithm of one well-known children's medical center.
The requirement for early postnatal surgical intervention is virtually confined to relieving outflow obstruction (usually boys with posterior urethral valves) and relieving gross hydronephrosis.
Surgical correction of reflux and ureteral reimplantations involve the development of an adequate length of submucosal ureter as it courses into the bladder (see Image 30). It may take several months for inflammatory changes to resolve and the antireflux 1-way mechanism to become competent. The incidence of persistent VUR requiring repeat surgery is between 1% and 3%, usually the result of a short submucosal tunnel or unrecognized neuropathic bladder.
Other surgical techniques include endoscopic submucosal injection of materials to effect bulking of either the subureteric space or proximal ureter resulting in coaptation. Teflon has been the most widely used and studied agent, though reports of granulomas, particle migration, and embolization have curtailed its use in the United States. Other materials include biodegradable glutaraldehyde cross-linked bovine collagen (GAX-collagen), Macroplastique particles, polyvinyl alcohol, and autologous materials such as fat.
Bladder training and techniques to avoid constipation may also be considered to lessen VUR.
Fefferman NR, Sabach AS, Rivera R, Milla S, Pinkney LP, Strubel NA, et al. The efficacy of digital fluoroscopic image capture in the evaluation of vesicoureteral reflux in children. Pediatr Radiol. Aug 29 2009;[Medline].
Novak TE, Mathews R, Martz K, Neu A. Progression of chronic kidney disease in children with vesicoureteral reflux: the North American Pediatric Renal Trials Collaborative Studies Database. J Urol. Oct 2009;182(4 Suppl):1678-81. [Medline].
Menezes M, Puri P. Familial vesicoureteral reflux--is screening beneficial?. J Urol. Oct 2009;182(4 Suppl):1673-7. [Medline].
Mingin G. Vesicoureteral reflux, urinary tract infection and renal scarring: sorting it all out. J Urol. Nov 2008;180(5):1884-5. [Medline].
Zaffanello M, Franchini M, Brugnara M, Fanos V. Evaluating kidney damage from vesico-ureteral reflux in children. Saudi J Kidney Dis Transpl. Jan 2009;20(1):57-68. [Medline].
Acar B, Arikan FI, Germiyanoglu C, Dallar Y. Influence of high bladder pressure on vesicoureteral reflux and its resolution. Urol Int. 2009;82(1):77-80. [Medline].
Papadopoulou F, Anthopoulou A, Siomou E, Efremidis S, Tsamboulas C, Darge K. Harmonic voiding urosonography with a second-generation contrast agent for the diagnosis of vesicoureteral reflux. Pediatr Radiol. Mar 2009;39(3):239-44. [Medline].
Sjöström S, Jodal U, Sixt R, Bachelard M, Sillén U. Longitudinal Development of Renal Damage and Renal Function in Infants With High Grade Vesicoureteral Reflux. J Urol. Mar 18 2009;[Medline].
Sjöström S, Bachelard M, Sixt R, Sillén U. Change of urodynamic patterns in infants with dilating vesicoureteral reflux: 3-year followup. J Urol. Nov 2009;182(5):2446-53. [Medline].
Ziessman HA, Majd M. Importance of methodology on (99m)technetium dimercapto-succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. J Urol. Jul 2009;182(1):272-9. [Medline].
Belman BA, Lowell RK, Kramer SA. Clinical Pediatric Urology. 4th ed. 2002.
Chudleigh T. Mild pyelectasis. Prenat Diagn. Nov 2001;21(11):936-41. [Medline].
Darge K. Diagnosis of vesicoureteral reflux with ultrasonography. Pediatr Nephrol. Jan 2002;17(1):52-60. [Medline].
Devriendt K, Groenen P, Van Esch H, et al. Vesico-ureteral reflux: a genetic condition?. Eur J Pediatr. Apr 1998;157(4):265-71. [Medline].
Dunnick NR, Sandler CM, Newhouse JH. Textbook of Uroradiology. 3rd ed. 2001: 330-3.
Hellstrom M, Jacobsson B. Diagnosis of vesico-ureteric reflux. Acta Paediatr Suppl. Nov 1999;88(431):3-12. [Medline].
Joyner BD, Atala A. Endoscopic substances for the treatment of vesicoureteral reflux. Urology. Oct 1997;50(4):489-94. [Medline].
Koff SA, Wagner TT, Jayanthi VR. The relationship among dysfunctional elimination syndromes, primary vesicoureteral reflux and urinary tract infections in children. J Urol. Sep 1998;160(3 Pt 2):1019-22. [Medline].
Lebowitz RL, Olbing H, Parkkulainen KV, et al. International system of radiographic grading of vesicoureteric reflux. International Reflux Study in Children. Pediatr Radiol. 1985;15(2):105-9. [Medline].
McNeil DR, Tukey JW. Higher-order diagnosis of two-way tables, illustrated on two sets ofdemographic empirical distributions. Biometrics. Jun 1975;31(2):487-510. [Medline].
Noe HN. The current status of screening for vesicoureteral reflux. Pediatr Nephrol. Oct 1995;9(5):638-41. [Medline].
Pollack HM, McClennan BL. Clinical Urography, Vol 1. 2nd ed. 2000.
Ritchey ML, Bloom D. Report of the American Academy of Pediatrics Section of Urology meeting. Pediatr Nephrol. Oct 1995;9(5):642-6. [Medline].
Sargent MA. What is the normal prevalence of vesicoureteral reflux?. Pediatr Radiol. Sep 2000;30(9):587-93. [Medline].
Shaikh N, Hoberman A, Wise B, et al. Dysfunctional elimination syndrome: is it related to urinary tract infection or vesicoureteral reflux diagnosed early in life?. Pediatrics. Nov 2003;112(5):1134-7. [Medline].
Sillen U. Vesicoureteral reflux in infants. Pediatr Nephrol. May 1999;13(4):355-61. [Medline].
Thrall JH, Ziessman HA. Nuclear Medicine: The Requisites. 2nd ed. 2001: 351-7.
vesicoureteral reflux, VUR, reflux nephropathy, posterior urethral valves, urinary tract infection, UTI
Kevin F McCarthy, MD, Staff Physician, Department of Radiology, National Naval Medical Center
Kevin F McCarthy, MD is a member of the following medical societies: American College of Radiology and Radiological Society of North America
Disclosure: Nothing to disclose.
Veronica Rooks, MD, Military Chief of Pediatric Radiology, Pediatric Radiologist, Tripler Army Medical Center; Assistant Professor of Radiology and Radiological Sciences, Uniformed Services University of the Health Sciences
Veronica Rooks, MD is a member of the following medical societies: American College of Radiology, American Roentgen Ray Society, Association of Program Directors in Radiology, Radiological Society of North America, and Society for Pediatric Radiology
Disclosure: Nothing to disclose.
Henrique M Lederman, MD, PhD, Consulting Staff, Department of Radiology, LeBonheur Children's Medical Center and St Jude Children's Research Hospital; Professor of Radiology and Pediatric Radiology, Chief, Division of Diagnostic Imaging in Pediatrics, Federal University of Sao Paulo, Brazil
Henrique M Lederman, MD, PhD is a member of the following medical societies: Society for Pediatric Radiology
Disclosure: Nothing to disclose.
Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.
Robert M Krasny, MD, Resolution Imaging Medical Corporation
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.
Eugene C Lin, MD, Consulting Radiologist, Virginia Mason Medical Center; Clinical Assistant Professor of Radiology, University of Washington School of Medicine
Eugene C Lin, MD is a member of the following medical societies: American College of Nuclear Medicine, American College of Radiology, Radiological Society of North America, and Society of Nuclear Medicine
Disclosure: Nothing to disclose.
Related eMedicine topics
Vesicoureteral Reflux (Pediatrics: surgery)
Vesicoureteral Reflux (Urology)
Reflux Nephropathy
Pyelonephritis, Chronic
Radiographic Evaluation of the Pediatric Urinary Tract
Clinical guidelines
Vesicoureteric reflux (VUR). In: Guidelines on paediatric urology.
European Association of Urology - Medical Specialty Society
European Society for Paediatric Urology - Medical Specialty Society. 2008 Mar. 6 pages. NGC:006510
Urinary tract infections in children. In: Guidelines on the management of urinary and male genital tract infections.
European Association of Urology - Medical Specialty Society. 2008 Mar. 13 pages. NGC:006488
ACR Appropriateness Criteria® urinary tract infection—child.
American College of Radiology - Medical Specialty Society. 1999 (revised 2006). 7 pages. NGC:005552
Clinical trials
Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR)
Determination of Voiding Patterns of Children With Vesicoureteral Reflux
Evaluation of the Efficiency of Autologous Adipocytes Graft in Endoscopic Treatment in Vesico-Renal Reflux in Children
© 1994-
by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)